# Effect of Zinc on Glucose Homeostasis

Study · id `cardio:ct-nct05835037` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05835037](<https://clinicaltrials.gov/study/NCT05835037>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05835037

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05835037. Randomized; double masking; primary purpose basic science. Start 2024-02-16 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05835037, source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)
- Started: 2024-02-16 (actual) (ClinicalTrials.gov record NCT05835037, source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT05835037, source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT05835037, source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05835037, source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05835037-2026-07-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effect of Zinc on Glucose Homeostasis
- Condition: Prediabetic State
- Condition: Hyperglycemia
- Intervention (Drug): Zinc Gluconate 30 MG
- Intervention (Drug): Placebo
- Lead sponsor: University of Maryland, Baltimore
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: University of Maryland, Baltimore (`cardio:org-university-of-maryland-baltimore`)

## Provenance

Content hash: d8fa986c3859e5d10209ff3197c52ba8b2fae0220d19abc3b76213bfc763b65d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
